APOA1 and coronary artery disorder: Kane’s laboratory was the first to identify preβ-1 HDL and has documented that elevated levels of preβ-1 HDL, or an increased proportion of apoA-I in preβ-1 HDL, are associated with a higher risk of CHD [19,40].